Cystoid macular edema (CME) also known as Irvine Gass Syndrome is a painless disorder affecting the central retina or macula. This condition is characterized by multiple cysts like areas of fluid in the macula causing retinal swelling or edema. CME is the retinal thickening of macula due to disruption of the normal blood-retinal barrier which leads to leakage from the perifoveal retinal capillaries causing accumulation of fluid within the intracellular spaces of the retina, mainly in the outer plexiform layer. CME is of two types: pseudophakic and nonpseudophakic cystoid macular edema. Pseudophakic cystoids macular edema is when the cause of occurrence is known while nonpseudophakic is the condition where no specific clinical findings have been observed. Symptoms of cystoids macular edema are blurred or decreased central vision.
The cause of CME is not completely known though it may be accompanied by various diseases such as uveitis, vein occlusion or diabetes. It is also known to occur commonly after cataract surgery. Various risk factors associated with cystoids macular edema are penetrating keratoplasty (corneal transplant), retinal surgery, chronic renal failure, retinal vein occlusion, retinitis pigmentosa, systemic medication and topical prostaglandin analogs for glaucoma..No significant racial or sex related predilection exists for this condition. However, cystoids macular edema can occur at any age based on the etiology, though advanced age is at higher risk.
In 2018, the global Cystoid Macular Edema market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Cystoid Macular Edema status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cystoid Macular Edema development in United States, Europe and China.
The key players covered in this study
Sanwa Kagaku Kenkyusho
Johns Hopkins University
Wake Forest University
IOL Research Center
Rabin Medical Center
Wills Eye Institute
Market segment by Type, the product can be split into
Non Steroidal Anti-Inflammatory Drugs
Anti- Vascular Endothelial Growth Factor (VEGF) Agents
Carbonic Anhydrase Inhibitors
Market segment by Application, split into
Ambulatory Surgical Centers
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global Cystoid Macular Edema status, future forecast, growth opportunity, key market and key players.
To present the Cystoid Macular Edema development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Cystoid Macular Edema are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.